Collegium Pharmaceutical ... (COLL)
32.91
-0.27 (-0.81%)
At close: Jan 15, 2025, 9:51 AM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Net Income | 48.16M | -25.00M | 71.52M | 26.75M | -22.72M | -39.13M | -74.86M | -94.18M | -27.25M | -17.92M | -16.20M |
| Depreciation & Amortization | 149.26M | 138.94M | 68.92M | 61.55M | 15.48M | 110.91M | 594.00K | 655.00K | 171.00K | 187.00K | 169.00K |
| Stock-Based Compensation | 27.14M | 22.87M | 24.25M | 21.91M | 16.53M | 13.78M | 7.95M | 5.79M | 2.21M | 22.00K | 62.00K |
| Other Working Capital | -1.09M | -38.50M | 44.13M | -10.43M | 20.92M | 126.10M | 9.26M | 10.59M | 2.04M | -1.21M | 188.00K |
| Other Non-Cash Items | 30.62M | 8.52M | 3.42M | 9.03M | 313.00K | 19.28M | -34.00K | -34.00K | -28.00K | -20.00K | -9.00K |
| Deferred Income Tax | -2.15M | -8.39M | -78.04M | n/a | n/a | n/a | 1.84M | n/a | n/a | n/a | 79.00K |
| Change in Working Capital | 21.73M | -12.71M | 13.49M | -25.30M | 18.18M | 64.55M | -2.50M | 12.71M | 3.34M | -219.00K | -634.00K |
| Operating Cash Flow | 274.75M | 124.23M | 103.56M | 93.94M | 27.78M | 169.39M | -67.02M | -75.05M | -21.57M | -17.95M | -16.53M |
| Capital Expenditures | -461.00K | -1.62M | -1.94M | -373.77M | -6.44M | -24.35M | -990.00K | -2.98M | -362.00K | -8.00K | -206.00K |
| Acquisitions | n/a | -572.07M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -92.35M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 22.00M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | -368.23M | n/a | -18.88M | n/a | -2.50M | n/a | n/a | n/a |
| Investing Cash Flow | -70.81M | -573.69M | -1.94M | -373.77M | -6.44M | -24.35M | -990.00K | -2.98M | -362.00K | -8.00K | -206.00K |
| Debt Repayment | -65.92M | 442.68M | -50.00M | 281.39M | n/a | 10.02M | -2.67M | -2.67M | -1.34M | 11.97M | 395.00K |
| Common Stock Repurchased | -75.00M | -14.06M | -47.86M | -2.25M | -822.00K | -560.00K | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -24.57M | -24.57M | n/a | n/a |
| Other Financial Acitivies | 740.00K | 8.10M | 8.56M | 5.08M | 2.04M | -127.19M | 1.81M | 885.00K | 69.88M | 72.00K | 11.96M |
| Financial Cash Flow | -140.18M | 436.72M | -89.30M | 286.47M | 2.04M | -117.20M | 33.48M | 135.56M | 115.99M | 12.04M | 12.35M |
| Net Cash Flow | 63.76M | -12.74M | 12.31M | 6.64M | 23.39M | 27.84M | -34.53M | 57.53M | 94.06M | -5.92M | -4.38M |
| Free Cash Flow | 274.29M | 122.61M | 101.61M | -279.83M | 21.34M | 145.04M | -68.01M | -78.03M | -21.93M | -17.95M | -16.74M |